Early trial tests Double-Punch cancer drug combo
NCT ID NCT02215720
Summary
This early-stage study tested the safety of combining two cancer drugs—cetuximab and temsirolimus—in adults with advanced solid tumors that no longer respond to standard treatments. Researchers wanted to see if blocking two different cancer growth pathways at once might be more effective than targeting just one. The main goal was to check for side effects and see if the combination showed any signs of slowing tumor growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gustave Roussy
Villejuif, Val de Marne, 94805, France
Conditions
Explore the condition pages connected to this study.